Effective Irinotecan (CPT-11)-containing liposomes: Intraliposomal conversion to the active metabolite SN-38

Japanese Journal of Cancer Research

Volumn 90, Issue 2, 1999, Pages 226-232

  Sadzuka, Yasuyuki ^a   Hirotsu, Sachiyo ^a   Hirota, Sadao ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Antitumor activity; Conversion; Irinotecan; SN 38; Targeting

Indexed keywords

7 ETHYL 10 HYDROXYCAMPTOTHECIN; DRUG METABOLITE; IRINOTECAN; LIPOSOME; PRODRUG;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONFOCAL MICROSCOPY; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

EID: 0033065077     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00737.x     Document Type: Article

References (19)

1. Coukell, A. J. and Spencer, C. M. Polyethylene glycolliposomal doxorubicin. Drugs, 53, 520-538 (1997).
2. Kawato, Y., Aonuma, M., Hirota, Y., Kuga, H. and Sato, K. Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11. Cancer Res., 51, 4187-4191 (1991).
3. Negoro, S., Fukuoka, M., Niitani, H., Suzuki, A., Nakabayashi, T., Kimura, M., Motomiya, M., Kurita, Y., Hasegawa, K. and Taguchi, T. A phase II study of CPT-11, a camptothecin derivative, in patients with primary lung cancer. Jpn. J. Cancer Chemother., 18, 1013-1019 (1991).
4. Potmesil, M. Camptothecins: from bench research to hospital wards. Cancer Res., 54, 1431-1439 (1994).
5. Sadzuka, Y., Hirotsu, S., Miyagishima, A., Nozawa, Y. and Hirota, S. The study of polyethyleneglycol-coated liposomes containing CPT-11. J. Liposome Res., 7, 241-260 (1997).
6. Sadzuka, Y., Hirotsu, S. and Hirota, S. Effect of liposomalization on the antitumor activity, side effect and tissue distribution of CPT-11. Cancer Lett., 127, 99-106 (1998).
7. Bangham, A. D., Standish, M. M. and Watkins, J. C. Diffusion of univalent ion across the lamellae of swollen phospholipids. J. Mol. Biol., 13, 238-252 (1965).
8. Sasaki, Y., Yoshida, Y., Sudoh, K., Hakusui, H., Fujii, H., Ohtsu, T., Wakita, H., Igarashi, T. and Itoh, K. Pharmacological correlation between total drug concentration and lactones of CPT-11 and SN-38 in patients treated with CPT-11. Jpn. J. Cancer Res., 86, 111-116 (1995).
9. Burke, T. G., Munshi, C. B., Mi, Z. and Jiang, Y. The important role of albumin in determining the relative human blood stabilities of the camptothecin anticancer drugs. J. Pharm. Sci., 84, 518-519 (1995).
10. Jaxel, C., Kohn, K. W., Wani, M. C., Wall, M. E. and Pommier, Y. Structure-activity study of the actions of camptothecin derivatives on mammalian topoisomerase I. Cancer Res., 49, 1465-1469 (1989).
11. Kurono, Y., Miyajima, M. and Ikeda, K. Interaction of camptothecin derivatives with human plasma proteins. J. Pharm. Soc. Jpn., 113, 167-175 (1993) (in Japanese).
12. Mi, Z., Malak, H. and Burke, T. G. Reduced albumin binding promotes the stability and activity of topotecan in human blood. Biochemistry, 34, 13722-13728 (1995).
13. Burke, T. G., Staubus, A. E., Mishra, A. K. and Malak, H. Liposomal stabilization of camptothecin's lactone ring. J. Am. Chem. Soc., 114, 8318-8319 (1992).
14. Bosworth, M. E. and Hunt, C. A. Liposome disposition in vivo II. J. Pharm. Sci., 71, 100-104 (1982).
15. Sadzuka, Y. and Hirota, S. Does the amount of an antitumor agent entrapped in liposomes influence its tissue distribution and cell uptake? Cancer Lett., 131, 163-170 (1998).
16. Chow, D. D., Essien, H. E., Padki, M. M. and Hwang, K. J. Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect. J. Pharmacol. Exp. Ther., 248, 506-513 (1989).
17. Kume, Y., Maeda, F., Harashima, H. and Kiwada, H. Saturable, non-Michaelis-Menten type uptake of liposomes by the reticuloendothelial system. J. Pharm. Pharmacol., 43, 162-166 (1991).
18. Harashima, H., Kume, Y., Yamae, C. and Kiwada, H. Non-Michaelis-Menten type hepatic uptake of liposomes in the rat. J. Pharm. Pharmacol., 44, 707-712 (1992).
19. Kawato, Y., Aonuma, M., Matsumoto, K. and Sato, K. Production of SN-38, a main metabolite of the camptothecin derivative CPT-11, and its species and tissue specificities. Xenobio. Met. Disp., 6, 899-907 (1991).